Claire Seedhouse

2.2k total citations
62 papers, 1.7k citations indexed

About

Claire Seedhouse is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Claire Seedhouse has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 32 papers in Hematology and 20 papers in Oncology. Recurrent topics in Claire Seedhouse's work include Acute Myeloid Leukemia Research (29 papers), DNA Repair Mechanisms (17 papers) and Drug Transport and Resistance Mechanisms (9 papers). Claire Seedhouse is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), DNA Repair Mechanisms (17 papers) and Drug Transport and Resistance Mechanisms (9 papers). Claire Seedhouse collaborates with scholars based in United Kingdom, United States and Malaysia. Claire Seedhouse's co-authors include Nigel H. Russell, Emma Das‐Gupta, Monica Pallis, Martin Grundy, Srinivasan Madhusudan, Rebeka Sultana, Stephen Chan, Tarek M.A. Abdel-Fatah, Rachel Abbotts and Mays Jawad and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Claire Seedhouse

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Seedhouse United Kingdom 25 1.1k 548 547 307 246 62 1.7k
Oliver Galm Germany 23 1.5k 1.3× 436 0.8× 602 1.1× 100 0.3× 246 1.0× 51 2.0k
Andreas Tobler Switzerland 24 705 0.6× 394 0.7× 332 0.6× 103 0.3× 127 0.5× 49 1.2k
Sören Lehmann Sweden 27 1.2k 1.1× 667 1.2× 1.2k 2.3× 363 1.2× 353 1.4× 77 2.3k
Livia Manzella Italy 23 878 0.8× 467 0.9× 456 0.8× 108 0.4× 283 1.2× 68 1.8k
Thibault De La Motte Rouge France 21 692 0.6× 479 0.9× 216 0.4× 100 0.3× 329 1.3× 99 1.7k
Fumihiko Hayakawa Japan 26 1.4k 1.2× 624 1.1× 1.1k 2.0× 234 0.8× 239 1.0× 85 2.4k
Carsten Grüllich Germany 25 557 0.5× 493 0.9× 258 0.5× 101 0.3× 188 0.8× 90 1.5k
Gabriel Ghiaur United States 25 934 0.8× 479 0.9× 725 1.3× 90 0.3× 252 1.0× 87 1.9k
Antonius W.M. Boersma Netherlands 21 1.3k 1.2× 608 1.1× 178 0.3× 51 0.2× 820 3.3× 28 2.0k

Countries citing papers authored by Claire Seedhouse

Since Specialization
Citations

This map shows the geographic impact of Claire Seedhouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Seedhouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Seedhouse more than expected).

Fields of papers citing papers by Claire Seedhouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Seedhouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Seedhouse. The network helps show where Claire Seedhouse may publish in the future.

Co-authorship network of co-authors of Claire Seedhouse

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Seedhouse. A scholar is included among the top collaborators of Claire Seedhouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Seedhouse. Claire Seedhouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Jamie, Gemma Clarke, Michelle M. Lister, et al.. (2021). Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samples. Journal of Medical Microbiology. 70(3). 7 indexed citations
2.
Seedhouse, Claire, et al.. (2020). Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4–Not deadenylase in non-Hodgkin lymphoma. Leukemia & lymphoma. 62(2). 281–290. 8 indexed citations
3.
Bailey, G. D., et al.. (2020). Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia. Scientific Reports. 10(1). 17695–17695. 5 indexed citations
4.
Seedhouse, Claire, et al.. (2019). Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 20(11). 2739–2739. 7 indexed citations
5.
Ali, Reem, Michael S. Toss, Andrew R. Green, et al.. (2018). Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. Cancer Research. 78(24). 6818–6827. 29 indexed citations
6.
Sultana, Rebeka, Tarek M.A. Abdel-Fatah, Christina J. Perry, et al.. (2013). Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells. PLoS ONE. 8(2). e57098–e57098. 65 indexed citations
7.
Sultana, Rebeka, Tarek M.A. Abdel-Fatah, Rachel Abbotts, et al.. (2012). Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy. Cancer Research. 73(5). 1621–1634. 77 indexed citations
9.
Abdel-Fatah, Tarek M.A., Rebeka Sultana, Rachel Abbotts, et al.. (2012). Clinicopathological and functional significance of XRCC1 expression in ovarian cancer. International Journal of Cancer. 132(12). 2778–2786. 54 indexed citations
10.
Sultana, Rehena, Tarek M.A. Abdel-Fatah, Nada Albarakati, et al.. (2012). 275 Targeting XRCC1 (X-ray Repair Cross-complementing Gene 1), a Key DNA Base Excision Repair Protein for Personalized Therapy in Breast and Ovarian Cancer. European Journal of Cancer. 48. 85–85. 4 indexed citations
11.
Grundy, Martin, et al.. (2010). The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 9(3). 661–672. 32 indexed citations
12.
Seedhouse, Claire, et al.. (2009). FLT3‐ITD expression levels and their effect on STAT5 in AML with and without NPM mutations. British Journal of Haematology. 147(5). 653–661. 9 indexed citations
13.
14.
Jawad, Mays, Claire Seedhouse, Nigel H. Russell, & Mark Plumb. (2006). Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia. Blood. 108(12). 3916–3918. 36 indexed citations
15.
Jawad, Mays, Claire Seedhouse, Nigel H. Russell, & Mark Plumb. (2006). Polymorphisms in Human Homeobox HLX1 and DNA Repair RAD51 Genes Increase the Risk of Therapy-Related Acute Myeloid Leukemia.. Blood. 108(11). 1171–1171. 1 indexed citations
16.
Seedhouse, Claire, Hannah Hunter, Bethan Lloyd‐Lewis, et al.. (2006). DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia. 20(12). 2130–2136. 66 indexed citations
17.
Bradbury, Dawn A., Deborah Clarke, Claire Seedhouse, et al.. (2005). Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites. Journal of Biological Chemistry. 280(34). 29993–30000. 81 indexed citations
19.
Seedhouse, Claire, et al.. (2003). BAT‐25 and BAT‐26, two mononucleotide microsatellites, are not sensitive markers of microsatellite instability in acute myeloid leukaemia. British Journal of Haematology. 124(2). 160–165. 13 indexed citations
20.
Seedhouse, Claire, Geoffrey P. Margison, J.H. Hendry, Ali H. Hajeer, & M. J. Embleton. (2001). Anti-8-oxo-2′-deoxyguanosine Phage Antibodies: Isolation, Characterization, and Relationship to Disease States. Biochemical and Biophysical Research Communications. 280(3). 595–604. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026